- Home
- NIU vs ALEC Comparison
NIU vs ALEC Comparison
Compare NIU & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIU | ALEC |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.8M | 167.6M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NIU | ALEC |
|---|---|---|
| Price | $1.95 | $2.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $3.50 | ★ $4.83 |
| AVG Volume (30 Days) | 155.3K | ★ 1.4M |
| Earning Date | 05-18-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | $25.54 | $2.03 |
| Revenue Next Year | $17.70 | $29.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.90 | $1.09 |
| 52 Week High | $5.67 | $3.40 |
Technical Indicators
Market Signals| Indicator | NIU | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 36.52 | 61.46 |
| Support Level | $1.90 | $1.93 |
| Resistance Level | $2.04 | $2.58 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 21.43 | 65.29 |
Price Performance
Historical ComparisonAbout NIU Niu Technologies
Niu Technologies designs, manufactures, and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycles, mopeds, and bicycle series, including the NQi, MQi, UQi, FQi series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.